Radiopharmaceuticals for NUC MED exercising OY3
Ended Awarded Last action
- Contract number
- 36C25021N0219
- Awardee
-
Schaaf Drugs, LLC UEI LSEHGNVLAVX5
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $62,200
Award facts
- Contract value 8% obligated
-
- $480,212.55 Current, with exercised options
- $776,248.43 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Lima, OH 45801, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$63,800 | |
| Original award | $126,000 |
About this award
Schaaf Drugs, LLC, doing business as Heartlight Pharmacy Services, received a delivery order award from the Department of Veterans Affairs' Veterans Integrated Service Network 10 (VISN 10) for radiopharmaceuticals supporting nuclear medicine exercises. This firm fixed-price delivery order, valued at $776K, was awarded on January 6, 2021, with an ultimate completion date of January 5, 2023. The contract carries no set-aside designation and represents performance at the company's Lima, Ohio location. VISN 10, which serves the VA healthcare systems in Ohio and Indiana, utilizes this contract to procure specialized medical isotopes and radiopharmaceutical products essential for diagnostic imaging and nuclear medicine treatment programs serving veterans across the region.
Schaaf Drugs has established itself as a key specialized supplier to the VA, holding multiple indefinite delivery contracts for radiopharmaceutical drugs and radioactive isotopes with potential values ranging from approximately $340K to $3.9 million. The company supplies critical diagnostic and therapeutic radiopharmaceuticals including Technetium-99m formulations, Thallium-201, Iodine-123, and other specialized medical isotopes required for veteran patient care. All of the company's federal contract awards have been issued without set-aside designations, with Schaaf Drugs serving as prime contractor exclusively. The company's consistent focus on serving VISN 10 demonstrates deep specialization in meeting the nuclear medicine procurement requirements of the VA healthcare system.
Quick answers
Who was awarded contract 36C25021N0219?
36C25021N0219 was awarded to Schaaf Drugs, LLC by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 6, 2021.
How much is contract 36C25021N0219 worth?
The government has obligated $62,200 on 36C25021N0219. Its current value, with exercised options, is $480,213. Its potential value, with all options, is $776,248.
Is contract 36C25021N0219 an order under another contract?
Yes. 36C25021N0219 is a delivery order under 36C25018D0047, an indefinite delivery contract.
Was contract 36C25021N0219 competed?
The extent of competition for 36C25021N0219 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award